The 2023 Influenza Vaccine Production & Distribution Market Report provides insights into both the previous and current flu seasons, vaccine makeup and effectiveness, and the overall decline in vaccine coverage in the U.S.
- Doses distributed: 173.4 million doses of the influenza vaccine were distributed during the 2022–2023 flu season.
- Vaccine effectiveness: A 54% vaccine effectiveness was estimated for the 2022–2023 flu season, the highest since 2013.
- Adult vaccination rate: 46.9% of U.S. adults received their influenza vaccine in the 2022–2023 flu season.
Members can access a single-license download of the full report via the Member Download button. Organization-wide PDF licenses and single-license downloads can be purchased below.